Cyclo Therapeutics, Inc. (CYTH) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 123 transactions totaling $6.1M, demonstrating a bullish sentiment with $6.1M in net insider flow. The most recent transaction on Aug 16, 2024 involved a transaction of 18,354 shares valued at $0.
No significant insider buying has been recorded for CYTH in the recent period.
No significant insider selling has been recorded for CYTH in the recent period.
Based on recent SEC filings, insider sentiment for CYTH is bullish with an Insider Alignment Score of 100/100 and a net flow of $6.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Cyclo Therapeutics, Inc. (CYTH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading CYTH stock, having executed 123 transactions in the past 90 days. The most active insider is Holdings, Inc. Rafael (Executive), who has made 2 transactions totaling $6.8M.
Get notified when executives and directors at CYTH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | Sieger Markus | Executive | Award | 18,354 | $N/A | $0 | |
| Aug 16, 2024 | Rick Strattan Ce | Executive | Award | 9,524 | $N/A | $0 | |
| Aug 16, 2024 | M. Toig Randall | Executive | Award | 10,516 | $N/A | $0 | |
| Aug 16, 2024 | Cross Shawn | Executive | Award | 9,028 | $N/A | $0 | |
| Aug 16, 2024 | Wong Vivien | Executive | Award | 7,937 | $N/A | $0 | |
| Aug 16, 2024 | Conkling William | Executive | Award | 8,731 | $N/A | $0 | |
| Aug 16, 2024 | S. Shanahan William | Executive | Award | 7,937 | $N/A | $0 | |
| Jun 3, 2024 | Conkling William | Executive | Award | 8,594 | $N/A | $0 | |
| Jun 3, 2024 | Wong Vivien | Executive | Award | 7,813 | $N/A | $0 | |
| Jun 3, 2024 | Cross Shawn | Executive | Award | 8,887 | $N/A | $0 | |
| Jun 3, 2024 | M. Toig Randall | Executive | Award | 10,352 | $N/A | $0 | |
| Jun 3, 2024 | Rick Strattan Ce | Executive | Award | 9,375 | $N/A | $0 | |
| Jun 3, 2024 | Patrick Ostronic Francis | Executive | Award | 10,743 | $N/A | $0 | |
| Jun 3, 2024 | Sieger Markus | Executive | Award | 18,067 | $N/A | $0 | |
| Jun 3, 2024 | S. Shanahan William | Executive | Award | 7,813 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 53 | $6.1M | 73.8% |
Exercise (Options)(X) | 6 | $2.2M | 25.9% |
Award(A) | 64 | $31.0K | 0.4% |
Insiders at Cyclo Therapeutics, Inc. are accumulating shares at an accelerated pace. With 15 insiders making 123 transactions totaling $6.1M in purchases versus $0 in sales, the net buying activity of $6.1M signals strong executive confidence. Holdings, Inc. Rafael (Executive) leads the buying activity with $6.8M in transactions across all time.